The PENTHELA brand, founded in 2013 (United States), from 13 sister brands and 2214 competing brands. The PENTHELA brand is owned by Lexicon Pharmaceuticals, a company listed in New York. PENTHELA is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
Lexicon Pharmaceuticals
(PENTHELA)
over 5 years*
USD 0.87